Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$13.73

-0.68 (-4.72%)

16:38
05/07/19
05/07
16:38
05/07/19
16:38

Evolent Health sees Q2 revenue $187.0M-$195.0M, consensus $193.93M

Sees Q2 Adjusted Services Revenue $149.0M-$153.0M, and True Health premiums revenue $42.0M-$46.0M; intersegment eliminations ($4.0M). Sees Q2 adjusted EBITDA ($8.0M)-($5.0M).

  • 07

    May

  • 05

    Jun

  • 12

    Jun

EVH Evolent Health
$13.73

-0.68 (-4.72%)

04/08/19
BARD
04/08/19
NO CHANGE
Target $25
BARD
Outperform
Evolent Health added as positive Fresh Pick at Baird
Baird analyst Matthew Gillmor maintained an Outperform rating on Evolent Health and added the stock as a positive Fresh Pick after traveling with management last week. In a research note to investors, Gillmor says he expects better clarity on the Passport rate situation over the near-term and, according to management, recent indications are positive. Additionally, the analyst says it is possible Evolent's relationship with Passport could expand, and says he is optimistic this, along with other factors, should drive accelerating revenue and EBITDA growth into 2020, resulting in material upside for the stock over the next 3-6 months.
04/11/19
ADAM
04/11/19
NO CHANGE
Target $19
ADAM
Buy
Passport news in KY removes overhang on Evolent's stock, says Canaccord
Canaccord analyst Richard Close maintained a Buy rating and $19 price target on Evolent Health after news outlets reported that Passport Health Plan said Medicaid rates in Kentucky were finalized this week, implying a blended positive rate increase of 4.7% for PHP. Close tells investors in a research note that the "positive" news removes a recent overhang on Evolent's stock and gives him greater confidence in the company's ability to achieve 2019 guidance. He would be an aggressive buyer of the stock.
04/11/19
CANT
04/11/19
NO CHANGE
Target $20
CANT
Overweight
Largest Evolent customer now 'much-less' likely to fail, says Cantor Fitzgerald
Multiple media sources yesterday indicated that Passport Health Plan was "cautiously optimistic" that the newly finalized Kentucky Medicaid rates will help provide a path for the plan's sustainability, Cantor Fitzgerald analyst Steven Halper tells investors in a research note. Passport is Evolent Health's largest customer. The news is an incremental positive for Evolent, as it is now "much-less likely that Passport will fail," says the analyst. He believes this should lift a "significant overhang" on Evolent Health shares. Halper reiterates an Overweight rating on the stock with a $20 price target.
04/11/19
COWN
04/11/19
NO CHANGE
Target $26
COWN
Outperform
Passport Health 'optimism' removes near-term overhang for Evolent, says Cowen
Passport Health Plan is "cautiously optimistic" that it will be able to remain in business in Kentucky after receiving an estimated 4.7% rate increase in its regions, Cowen analyst Charles Rhyee tells investors in a research note. He says this should remove a near-term overhang for Evolent Health, giving him confidence in the company's revenue outlook. The analyst, who maintains an Outperform rating and $26 price target on Evolent, believes the mid-high end of revenue and adjusted EBITDA guidance is now more achievable.

TODAY'S FREE FLY STORIES

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$9.12

-0.09 (-0.98%)

16:14
05/24/19
05/24
16:14
05/24/19
16:14
Syndicate
Breaking Syndicate news story on Translate Bio »

Translate Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

TEAM

Atlassian

$129.57

2.33 (1.83%)

16:11
05/24/19
05/24
16:11
05/24/19
16:11
Hot Stocks
Atlassian co-CEOs adopt new 10b5-1 trading plans »

Atlassian announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Jun

HIBB

Hibbett Sports

$23.90

4.06 (20.46%)

16:10
05/24/19
05/24
16:10
05/24/19
16:10
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MYOV

Myovant Sciences

$12.44

-0.415 (-3.23%)

16:09
05/24/19
05/24
16:09
05/24/19
16:09
Earnings
Myovant Sciences reports Q4 EPS ($1.07), consensus ($1.02) »

Cash and cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:06
05/24/19
05/24
16:06
05/24/19
16:06
Periodicals
TD Bank's Masrani says trade tensions put confidence at risk, Bloomberg says »

In an interview with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$71.06

1.07 (1.53%)

16:02
05/24/19
05/24
16:02
05/24/19
16:02
Recommendations
Copart analyst commentary  »

Outlook for Copart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

PFE

Pfizer

$41.96

0.04 (0.10%)

16:01
05/24/19
05/24
16:01
05/24/19
16:01
Hot Stocks
Pfizer says Phase 3 study of LYRICA did not meet primary endpoint »

Pfizer announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

IMMR

Immersion

$7.69

-0.03 (-0.39%)

15:55
05/24/19
05/24
15:55
05/24/19
15:55
Options
Immersion put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

S

Sprint

$6.98

0.03 (0.43%)

, TMUS

T-Mobile

$76.09

0.02 (0.03%)

15:30
05/24/19
05/24
15:30
05/24/19
15:30
Periodicals
FCC, DOJ may agree on T-Mobile deal for Sprint, NY Post says »

Ajit Pai, chairman of the…

S

Sprint

$6.98

0.03 (0.43%)

TMUS

T-Mobile

$76.09

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

BPMC

Blueprint Medicines

$84.69

1.65 (1.99%)

15:30
05/24/19
05/24
15:30
05/24/19
15:30
Options
Volatility play opened in Blueprint Medicines as shares add 2% to $84.60 »

Volatility play opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.